• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颈动脉粥样硬化患者的肠道微生物群改变

Gut Microbiome Alterations in Patients With Carotid Atherosclerosis.

作者信息

Chen Jingfeng, Qin Qian, Yan Su, Yang Yang, Yan Hang, Li Tiantian, Wang Lin, Gao Xinxin, Li Ang, Ding Suying

机构信息

Health Management Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

College of Public Health, Zhengzhou University, Zhengzhou, China.

出版信息

Front Cardiovasc Med. 2021 Nov 19;8:739093. doi: 10.3389/fcvm.2021.739093. eCollection 2021.

DOI:10.3389/fcvm.2021.739093
PMID:34869642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8639581/
Abstract

Carotid atherosclerosis (CAS) is a reflection of systemic atherosclerosis and the main pathological processes of cardiovascular disease (CVD), namely, carotid intima-media thickening, carotid plaque formation, and carotid stenosis. Accumulating evidence indicates that the gut microbiota plays an important role in CVD and gut-brain disorders, but the associations of the composition and metabolites of the gut microbiome with CAS have not been studied comprehensively. We performed a gut microbiome genome-wide association study in 31 patients with CAS and 51 healthy controls using whole-genome shotgun sequencing. We found that several risk factors (waist circumference, body mass index, diastolic blood pressure, systolic blood pressure, fasting blood glucose, glycated hemoglobin A1c, total cholesterol, triglyceride, and low-density lipoprotein cholesterol) and inflammatory markers (white blood cell count and absolute value of neutrophils) were significantly higher in the CAS group than in the control group. In addition, 21 species and 142 pathways were enriched in the CAS group, and 10 species and 1 pathway were enriched in the control group. Specifically, , and were the most abundant species in the CAS group, whereas , and were the most abundant species in the control group. Finally, we found that most gut microbes and microbial pathways that were enriched in the CAS group had significant positive correlations with clinical characteristics, whereas the microbes and pathways enriched in healthy controls had significant negative correlations with clinical characteristics excluding high-density lipoprotein cholesterol. In addition, the associations between gut microbes and some microbial pathways (short-chain fatty acid, lipopolysaccharide, and menaquinol biosynthesis) were identified. Our results indicate the existence of a cyclic pathway that elevates the circulating concentrations of trimethylamine-N-oxide in patients with CAS but reduces its concentrations in healthy controls.

摘要

颈动脉粥样硬化(CAS)是全身动脉粥样硬化的一种表现,也是心血管疾病(CVD)的主要病理过程,即颈动脉内膜中层增厚、颈动脉斑块形成和颈动脉狭窄。越来越多的证据表明,肠道微生物群在心血管疾病和肠脑疾病中起重要作用,但肠道微生物组的组成和代谢产物与CAS之间的关联尚未得到全面研究。我们使用全基因组鸟枪法测序对31例CAS患者和51例健康对照进行了肠道微生物组全基因组关联研究。我们发现,CAS组的几个风险因素(腰围、体重指数、舒张压、收缩压、空腹血糖、糖化血红蛋白A1c、总胆固醇、甘油三酯和低密度脂蛋白胆固醇)和炎症标志物(白细胞计数和中性粒细胞绝对值)显著高于对照组。此外,CAS组有21个物种和142条通路富集,对照组有10个物种和1条通路富集。具体而言, 、 和 是CAS组中最丰富的物种,而 、 和 是对照组中最丰富的物种。最后,我们发现,CAS组中富集的大多数肠道微生物和微生物通路与临床特征呈显著正相关,而健康对照组中富集的微生物和通路与除高密度脂蛋白胆固醇外的临床特征呈显著负相关。此外,还确定了肠道微生物与一些微生物通路(短链脂肪酸、脂多糖和甲基萘醌生物合成)之间的关联。我们的结果表明,存在一种循环途径,该途径会提高CAS患者血液中氧化三甲胺的循环浓度,但会降低健康对照者血液中氧化三甲胺的浓度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a4/8639581/7d7b65f69a57/fcvm-08-739093-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a4/8639581/8f3f9643c7fb/fcvm-08-739093-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a4/8639581/7cc5df2597fe/fcvm-08-739093-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a4/8639581/76a8f1e2f176/fcvm-08-739093-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a4/8639581/0290bd396abe/fcvm-08-739093-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a4/8639581/bf97d61125c6/fcvm-08-739093-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a4/8639581/7d7b65f69a57/fcvm-08-739093-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a4/8639581/8f3f9643c7fb/fcvm-08-739093-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a4/8639581/7cc5df2597fe/fcvm-08-739093-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a4/8639581/76a8f1e2f176/fcvm-08-739093-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a4/8639581/0290bd396abe/fcvm-08-739093-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a4/8639581/bf97d61125c6/fcvm-08-739093-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2a4/8639581/7d7b65f69a57/fcvm-08-739093-g0006.jpg

相似文献

1
Gut Microbiome Alterations in Patients With Carotid Atherosclerosis.颈动脉粥样硬化患者的肠道微生物群改变
Front Cardiovasc Med. 2021 Nov 19;8:739093. doi: 10.3389/fcvm.2021.739093. eCollection 2021.
2
A metagenome-wide association study of gut microbiome and visceral fat accumulation.一项关于肠道微生物群与内脏脂肪堆积的宏基因组关联研究。
Comput Struct Biotechnol J. 2020 Sep 20;18:2596-2609. doi: 10.1016/j.csbj.2020.09.026. eCollection 2020.
3
Gut Microbiome Alterations in Patients With Visceral Obesity Based on Quantitative Computed Tomography.基于定量计算机断层扫描的内脏型肥胖患者肠道微生物组的改变。
Front Cell Infect Microbiol. 2022 Jan 20;11:823262. doi: 10.3389/fcimb.2021.823262. eCollection 2021.
4
Gut microbiota, circulating inflammatory markers and metabolites, and carotid artery atherosclerosis in HIV infection.HIV 感染患者的肠道菌群、循环炎症标志物和代谢物与颈动脉粥样硬化。
Microbiome. 2023 May 27;11(1):119. doi: 10.1186/s40168-023-01566-2.
5
Structural and Functional Alterations of Gut Microbiota in Males With Hyperuricemia and High Levels of Liver Enzymes.高尿酸血症和高肝酶水平男性肠道微生物群的结构和功能改变
Front Med (Lausanne). 2021 Nov 19;8:779994. doi: 10.3389/fmed.2021.779994. eCollection 2021.
6
Comparison of gut microbiota in male MAFLD patients with varying liver stiffness.男性 MAFLD 患者不同肝硬度的肠道微生物组比较。
Front Cell Infect Microbiol. 2022 Aug 3;12:873048. doi: 10.3389/fcimb.2022.873048. eCollection 2022.
7
Alterations in the Salivary Microbiome and Metabolism in Patients With Carotid Atherosclerosis from Rural Northeast China.中国东北农村地区颈动脉粥样硬化患者唾液微生物组和代谢物的改变。
J Am Heart Assoc. 2024 Aug 6;13(15):e034014. doi: 10.1161/JAHA.123.034014. Epub 2024 Jul 31.
8
Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease.整合宏基因组学和代谢组学分析揭示慢性肾脏病严重程度特异性的肠道微生物组特征。
Theranostics. 2020 Apr 6;10(12):5398-5411. doi: 10.7150/thno.41725. eCollection 2020.
9
A Metagenome-Wide Association Study of the Gut Microbiome and Metabolic Syndrome.一项关于肠道微生物群与代谢综合征的宏基因组关联研究。
Front Microbiol. 2021 Jul 16;12:682721. doi: 10.3389/fmicb.2021.682721. eCollection 2021.
10
Exploration of Crucial Mediators for Carotid Atherosclerosis Pathogenesis Through Integration of Microbiome, Metabolome, and Transcriptome.通过整合微生物组、代谢组和转录组探索颈动脉粥样硬化发病机制的关键介质
Front Physiol. 2021 May 24;12:645212. doi: 10.3389/fphys.2021.645212. eCollection 2021.

引用本文的文献

1
The Emerging Role of the Gut Microbiome in Cerebral Cavernous Malformation: A New Novel Therapeutic Strategy?肠道微生物群在脑海绵状血管畸形中的新兴作用:一种新的治疗策略?
Int J Mol Sci. 2025 Sep 4;26(17):8622. doi: 10.3390/ijms26178622.
2
Gut microbiota regulate atherosclerosis via the gut-vascular axis: a scoping review of mechanisms and therapeutic interventions.肠道微生物群通过肠-血管轴调节动脉粥样硬化:机制与治疗干预的范围综述
Front Microbiol. 2025 Aug 8;16:1606309. doi: 10.3389/fmicb.2025.1606309. eCollection 2025.
3
Multi-omics integration reveals functional signatures of gut microbiome in atherosclerosis.

本文引用的文献

1
Gut Microbiome Alterations in Patients With Thyroid Nodules.甲状腺结节患者的肠道微生物组改变。
Front Cell Infect Microbiol. 2021 Mar 12;11:643968. doi: 10.3389/fcimb.2021.643968. eCollection 2021.
2
Carotid Atherosclerosis in Predicting Coronary Artery Disease: A Systematic Review and Meta-Analysis.颈动脉粥样硬化预测冠状动脉疾病:系统评价和荟萃分析。
Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):e224-e237. doi: 10.1161/ATVBAHA.120.315747. Epub 2021 Feb 25.
3
Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine--Oxide Response in Healthy Men.
多组学整合揭示了肠道微生物群在动脉粥样硬化中的功能特征。
Gut Microbes. 2025 Dec;17(1):2542384. doi: 10.1080/19490976.2025.2542384. Epub 2025 Aug 10.
4
Interactions between gut microbiota and cardiovascular drugs: effects on drug therapeutic effect and side effect.肠道微生物群与心血管药物之间的相互作用:对药物治疗效果和副作用的影响。
Front Cardiovasc Med. 2025 Jul 10;12:1570008. doi: 10.3389/fcvm.2025.1570008. eCollection 2025.
5
Causal effect of gut microbiota metabolic pathways on CSAG1 expression in chondrosarcoma: a mendelian randomization analysis.肠道微生物群代谢途径对软骨肉瘤中CSAG1表达的因果效应:孟德尔随机化分析
BMC Cancer. 2025 May 9;25(1):852. doi: 10.1186/s12885-025-14281-y.
6
Targeting gut microbiota to regulate the adaptive immune response in atherosclerosis.靶向肠道微生物群以调节动脉粥样硬化中的适应性免疫反应。
Front Cardiovasc Med. 2025 Jan 31;12:1502124. doi: 10.3389/fcvm.2025.1502124. eCollection 2025.
7
Oral Supplementation with the Short-Chain Fatty Acid Acetate Ameliorates Age-Related Arterial Dysfunction in Mice.口服补充短链脂肪酸乙酸可改善小鼠与年龄相关的动脉功能障碍。
Aging Biol. 2024;2. doi: 10.59368/agingbio.20240033. Epub 2024 Aug 27.
8
Unveiling the Role of Gut Microbiota and Metabolites in Autoimmune Thyroid Diseases: Emerging Perspectives.揭开肠道微生物群及其代谢物在自身免疫性甲状腺疾病中的作用:新的视角。
Int J Mol Sci. 2024 Oct 10;25(20):10918. doi: 10.3390/ijms252010918.
9
Intestinal microbiome as a diagnostic marker of coronary artery disease: a systematic review and meta-analysis.肠道微生物群作为冠状动脉疾病的诊断标志物:一项系统评价和荟萃分析。
Ann Med Surg (Lond). 2024 Sep 4;86(10):6105-6120. doi: 10.1097/MS9.0000000000002516. eCollection 2024 Oct.
10
Mediation effect of gut microbiota on the relationship between physical activity and carotid plaque.肠道微生物群对身体活动与颈动脉斑块之间关系的中介作用。
Front Microbiol. 2024 Jul 11;15:1432008. doi: 10.3389/fmicb.2024.1432008. eCollection 2024.
胆碱形式和肠道微生物组成对健康男性中三甲胺氧化物反应的影响。
Nutrients. 2020 Jul 25;12(8):2220. doi: 10.3390/nu12082220.
4
Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study.全球及区域颈动脉粥样硬化的流行率、负担及风险因素:一项系统评价、荟萃分析及建模研究。
Lancet Glob Health. 2020 May;8(5):e721-e729. doi: 10.1016/S2214-109X(20)30117-0.
5
The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation.糖尿病与动脉粥样硬化的关联:脂质和葡萄糖代谢及慢性炎症的作用。
Int J Mol Sci. 2020 Mar 6;21(5):1835. doi: 10.3390/ijms21051835.
6
Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study.血浆三甲胺 N-氧化物、胆碱、肉碱和甜菜碱与炎症和心血管代谢风险生物标志物及多民族队列肥胖表型研究中粪便微生物组的相关性。
Am J Clin Nutr. 2020 Jun 1;111(6):1226-1234. doi: 10.1093/ajcn/nqaa015.
7
Modifiable risk factors for carotid atherosclerosis: a meta-analysis and systematic review.颈动脉粥样硬化的可改变危险因素:一项荟萃分析与系统评价
Ann Transl Med. 2019 Nov;7(22):632. doi: 10.21037/atm.2019.10.115.
8
Role of gut microbiota in type 2 diabetes pathophysiology.肠道微生物群在 2 型糖尿病发病机制中的作用。
EBioMedicine. 2020 Jan;51:102590. doi: 10.1016/j.ebiom.2019.11.051. Epub 2020 Jan 3.
9
Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target.肠道微生物群依赖的标志物氧化三甲胺在促进心血管疾病中的作用:炎症机制、临床预后及作为治疗靶点的潜力
Front Pharmacol. 2019 Nov 19;10:1360. doi: 10.3389/fphar.2019.01360. eCollection 2019.
10
Helicobacter pylori infection selectively increases the risk for carotid atherosclerosis in young males.幽门螺杆菌感染可选择性增加年轻男性发生颈动脉粥样硬化的风险。
Atherosclerosis. 2019 Dec;291:71-77. doi: 10.1016/j.atherosclerosis.2019.10.005. Epub 2019 Oct 11.